Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 116.45 USD 2.49%
Market Cap: 632.3m USD
Have any thoughts about
Mesa Laboratories Inc?
Write Note

Mesa Laboratories Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mesa Laboratories Inc
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Accounts Payable
$6m
CAGR 3-Years
10%
CAGR 5-Years
21%
CAGR 10-Years
8%
Becton Dickinson and Co
NYSE:BDX
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accounts Payable
$907m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Accounts Payable
$1.3B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
15%
Abbott Laboratories
NYSE:ABT
Accounts Payable
$4.1B
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
16%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Payable
$218.7m
CAGR 3-Years
22%
CAGR 5-Years
11%
CAGR 10-Years
15%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
631.1m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
120.98 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Accounts Payable?
Accounts Payable
6m USD

Based on the financial report for Sep 30, 2024, Mesa Laboratories Inc's Accounts Payable amounts to 6m USD.

What is Mesa Laboratories Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
8%

Over the last year, the Accounts Payable growth was 25%. The average annual Accounts Payable growth rates for Mesa Laboratories Inc have been 10% over the past three years , 21% over the past five years , and 8% over the past ten years .

Back to Top